Clinical pathway of COVID-19 patients in primary health care in 30 European countries: Eurodata study.
COVID-19
Europe
patient care management
policy
primary health care
standard of care
Journal
The European journal of general practice
ISSN: 1751-1402
Titre abrégé: Eur J Gen Pract
Pays: England
ID NLM: 9513566
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
8
6
2023
pubmed:
22
3
2023
entrez:
21
3
2023
Statut:
ppublish
Résumé
Most COVID-19 patients were treated in primary health care (PHC) in Europe. To demonstrate the scope of PHC workflow during the COVID-19 pandemic emphasising similarities and differences of patient's clinical pathways in Europe. Descriptive, cross-sectional study with data acquired through a semi-structured questionnaire in PHC in 30 European countries, created ad hoc and agreed upon among all researchers who participated in the study. GPs from each country answered the approved questionnaire. Main variable: PHC COVID-19 acute clinical pathway. All variables were collected from each country as of September 2020. COVID-19 clinics in PHC facilities were organised in 8/30. Case detection and testing were performed in PHC in 27/30 countries. RT-PCR and lateral flow tests were performed in PHC in 23/30, free of charge with a medical prescription. Contact tracing was performed mainly by public health authorities. Mandatory isolation ranged from 5 to 14 days. Sick leave certification was given exclusively by GPs in 21/30 countries. Patient hotels or other resources to isolate patients were available in 12/30. Follow-up to monitor the symptoms and/or new complementary tests was made mainly by phone call (27/30). Chest X-ray and phlebotomy were performed in PHC in 18/30 and 23/30 countries, respectively. Oxygen and low-molecular-weight heparin were available in PHC (21/30). In Europe PHC participated in many steps to diagnose, treat and monitor COVID-19 patients. Differences among countries might be addressed at European level for the management of future pandemics.
Sections du résumé
BACKGROUND
UNASSIGNED
Most COVID-19 patients were treated in primary health care (PHC) in Europe.
OBJECTIVES
UNASSIGNED
To demonstrate the scope of PHC workflow during the COVID-19 pandemic emphasising similarities and differences of patient's clinical pathways in Europe.
METHODS
UNASSIGNED
Descriptive, cross-sectional study with data acquired through a semi-structured questionnaire in PHC in 30 European countries, created ad hoc and agreed upon among all researchers who participated in the study. GPs from each country answered the approved questionnaire. Main variable: PHC COVID-19 acute clinical pathway. All variables were collected from each country as of September 2020.
RESULTS
UNASSIGNED
COVID-19 clinics in PHC facilities were organised in 8/30. Case detection and testing were performed in PHC in 27/30 countries. RT-PCR and lateral flow tests were performed in PHC in 23/30, free of charge with a medical prescription. Contact tracing was performed mainly by public health authorities. Mandatory isolation ranged from 5 to 14 days. Sick leave certification was given exclusively by GPs in 21/30 countries. Patient hotels or other resources to isolate patients were available in 12/30. Follow-up to monitor the symptoms and/or new complementary tests was made mainly by phone call (27/30). Chest X-ray and phlebotomy were performed in PHC in 18/30 and 23/30 countries, respectively. Oxygen and low-molecular-weight heparin were available in PHC (21/30).
CONCLUSION
UNASSIGNED
In Europe PHC participated in many steps to diagnose, treat and monitor COVID-19 patients. Differences among countries might be addressed at European level for the management of future pandemics.
Identifiants
pubmed: 36943232
doi: 10.1080/13814788.2023.2182879
pmc: PMC10324993
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2182879Investigateurs
Asja Ćosić Divjak
(AĆ)
Maryher Delphin Peña
(MD)
Mila Gómez-Johansson
(M)
Miroslav Hanževački
(M)
Shushman Ivanna
(S)
Marijana Jandrić-Kočić
(M)
Milena Kostić
(M)
Anna Krztoń-Królewiecka
(A)
Martin Sattler
(M)
Natalija Saurek-Aleksandrovska
(N)
Canan Tuz Yilmaz
(CT)
Kirsi Valtonen
(K)
Kaliy Vasyl
(K)
Références
BMC Public Health. 2021 May 31;21(1):1023
pubmed: 34059034
Aten Primaria. 2021 Oct;53(8):102134
pubmed: 34237607
BMC Prim Care. 2022 Jan 15;23(1):11
pubmed: 35172744
Nat Med. 2021 Jun;27(6):964-980
pubmed: 34002090
Glob Public Health. 2020 Jul;15(7):925-934
pubmed: 32396447
Int J Infect Dis. 2021 Aug;109:203-208
pubmed: 34224870
J Eval Clin Pract. 2015 Aug;21(4):591-6
pubmed: 25756943
J Med Syst. 2020 Aug 10;44(9):164
pubmed: 32779002
Cochrane Database Syst Rev. 2022 Jul 22;7:CD013705
pubmed: 35866452
BMJ Open. 2020 Dec 8;10(12):e041622
pubmed: 33293398
BMJ Open. 2021 Mar 16;11(3):e045343
pubmed: 33727273
J Am Board Fam Med. 2021 Feb;34(Suppl):S95-S102
pubmed: 33622824
Eur J Gen Pract. 2020 Dec;26(1):129-133
pubmed: 32985278
BMC Fam Pract. 2019 Oct 28;20(1):146
pubmed: 31660860
Front Public Health. 2020 Oct 19;8:580546
pubmed: 33194983
JAMA Netw Open. 2021 Apr 1;4(4):e213990
pubmed: 33792728
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217
pubmed: 32519894
PLoS One. 2021 Mar 4;16(3):e0247774
pubmed: 33662012
BMC Fam Pract. 2021 Apr 29;22(1):83
pubmed: 33926382
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):699-704
pubmed: 32525856
PLoS One. 2021 Jun 4;16(6):e0252892
pubmed: 34086823